Search - tctmd.com

Displaying 61 - 80 of 146

Sort: Relevancy | Date

Presentation TCT 2023

What’s Next in Antithrombotic Therapy?

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

Aspirin or Clopidogrel for Chronic Management?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

DAPT After PCI: Do We Need It at All?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

DAPT Duration: Unsettled or Case Closed?

Presenter: Duk-Woo Park

October 24, 2023

Presentation TCT 2023

Guided Antiplatelet Therapy: Why, and in Whom?

Presenter: Jurrien Ten Berg

October 24, 2023

Presentation TCT 2023

Standardizing The Language Around DAPT: An ARC Initiative

Presenter: Davide Capodanno

October 24, 2023

Presentation TCT 2023

A Typical PCI Case in 2023 with Longitudinal Follow Up

Presenter: Mahesh Madhavan

October 24, 2023

Presentation TCT 2023

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Presenter: Sripal Bangalore

October 24, 2023

Presentation TVT 2023

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

Presenter: Tarun Chakravarty

June 08, 2023

Presentation TCT 2022

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

Presenter: Jennifer Rymer

September 19, 2022

Presentation TCT 2022

PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy

Presenter: Usman Baber

September 18, 2022

Presentation TCT 2022

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

Presenter: Jennifer Rymer

September 18, 2022

Presentation TCT 2022

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

Presenter: Dennis Narcisse

September 17, 2022

Presentation TCT 2022

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Presenter: Alexander Fanaroff

September 17, 2022

Presentation TVT 2022

Optimal antithrombotic regimen after transcatheter aortic valve replacement (TAVR): long term follow-up study

Presenter: Melissa Moey

June 09, 2022

Presentation TCT 2021

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

Presenter: Stephan Windecker

November 05, 2021

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

Presentation TCT 2020

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Presenter: Benjamin Peterson

October 14, 2020

Presentation JIM 2020

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Presenter: Giuseppe Tarantini

February 13, 2020

Advertisement

What’s Next in Antithrombotic Therapy?

Aspirin or Clopidogrel for Chronic Management?

DAPT After PCI: Do We Need It at All?

DAPT Duration: Unsettled or Case Closed?

Guided Antiplatelet Therapy: Why, and in Whom?

Standardizing The Language Around DAPT: An ARC Initiative

A Typical PCI Case in 2023 with Longitudinal Follow Up

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Prevention of and Antithrombotic Management for HALT and THV Thrombosis

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Optimal antithrombotic regimen after transcatheter aortic valve replacement (TAVR): long term follow-up study

Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR

Clopidogrel for Most!

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content